Literature DB >> 19654195

Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses.

John P A Ioannidis1.   

Abstract

Mesh：

Year:  2009        PMID： 19654195      PMCID： PMC2761440          DOI： 10.1503/cmaj.081086

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  51 in total

1.  Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses.

Authors:  L L Kjaergard; J Villumsen; C Gluud
Journal:  Ann Intern Med       Date:  2001-12-04       Impact factor: 25.391

2.  Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses.

Authors:  Fujian Song; Douglas G Altman; Anne-Marie Glenny; Jonathan J Deeks
Journal:  BMJ       Date:  2003-03-01

3.  Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research.

Authors:  Jonathan A C Sterne; Peter Jüni; Kenneth F Schulz; Douglas G Altman; Christopher Bartlett; Matthias Egger
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

4.  Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials.

Authors:  Ethan M Balk; Peter A L Bonis; Harry Moskowitz; Christopher H Schmid; John P A Ioannidis; Chenchen Wang; Joseph Lau
Journal:  JAMA       Date:  2002-06-12       Impact factor: 56.272

5.  Network meta-analysis for indirect treatment comparisons.

Authors:  Thomas Lumley
Journal:  Stat Med       Date:  2002-08-30       Impact factor: 2.373

6.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

7.  Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.

Authors:  An-Wen Chan; Karmela Krleza-Jerić; Isabelle Schmid; Douglas G Altman
Journal:  CMAJ       Date:  2004-09-28       Impact factor: 8.262

Review 8.  Availability of large-scale evidence on specific harms from systematic reviews of randomized trials.

Authors:  Panagiotis N Papanikolaou; John P A Ioannidis
Journal:  Am J Med       Date:  2004-10-15       Impact factor: 4.965

9.  Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas.

Authors:  J P Ioannidis; J Lau
Journal:  JAMA       Date:  2001 Jan 24-31       Impact factor: 56.272

10.  Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses.

Authors:  J Ioannidis; J Lau
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-23       Impact factor: 11.205
View more
  135 in total

Review 1.  Evidence-based surgery: barriers, solutions, and the role of evidence synthesis.

Authors:  George Garas; Amel Ibrahim; Hutan Ashrafian; Kamran Ahmed; Vanash Patel; Koji Okabayashi; Petros Skapinakis; Ara Darzi; Thanos Athanasiou
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

2.  Renoprotective effects of renin-angiotensin-aldosterone system blockers in type 2 diabetes: demystifying multiple treatment comparisons in a network meta-analysis.

Authors:  F Catalá-López
Journal:  Diabetologia       Date:  2012-06-23       Impact factor: 10.122

Review 3.  The genetics of multiple sclerosis: an up-to-date review.

Authors:  Pierre-Antoine Gourraud; Hanne F Harbo; Stephen L Hauser; Sergio E Baranzini
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

4.  Different black box warning labeling for same-class drugs.

Authors:  Orestis A Panagiotou; Despina G Contopoulos-Ioannidis; Panagiotis N Papanikolaou; Evangelia E Ntzani; John P A Ioannidis
Journal:  J Gen Intern Med       Date:  2011-02-01       Impact factor: 5.128

Review 5.  Knowledge creation: synthesis, tools and products.

Authors:  Melissa Brouwers; Dawn Stacey; Annette O'Connor
Journal:  CMAJ       Date:  2009-11-02       Impact factor: 8.262

Review 6.  (Neuro)Psychological Interventions for Non-Motor Symptoms in the Treatment of Patients with Parkinson's Disease: a Systematic Umbrella Review.

Authors:  Hanna Kampling; Lisa K Brendel; Oskar Mittag
Journal:  Neuropsychol Rev       Date:  2019-06-05       Impact factor: 7.444

7.  Umbrella reviews: what they are and why we need them.

Authors:  Stefania Papatheodorou
Journal:  Eur J Epidemiol       Date:  2019-03-09       Impact factor: 8.082

8.  The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: beyond qualitative synthesis.

Authors:  M Solmi; C U Correll; A F Carvalho; J P A Ioannidis
Journal:  Epidemiol Psychiatr Sci       Date:  2018-07-16       Impact factor: 6.892

Review 9.  Knowledge integration in cancer: current landscape and future prospects.

Authors:  John P A Ioannidis; Sheri D Schully; Tram Kim Lam; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-23       Impact factor: 4.254

10.  Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.

Authors:  Andrew W Bergen; Harold S Javitz; Ruth Krasnow; Denise Nishita; Martha Michel; David V Conti; Jinghua Liu; Won Lee; Christopher K Edlund; Sharon Hall; Pui-Yan Kwok; Neal L Benowitz; Timothy B Baker; Rachel F Tyndale; Caryn Lerman; Gary E Swan
Journal:  Pharmacogenet Genomics       Date:  2013-02       Impact factor: 2.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.